Variable neutralizing antibody responses to 10 SARS-CoV-2 variants in natural infection with wild- type (B.1) virus, Kappa (B.1.617.1), and Delta (B.1.617.2) variants and COVISHIELD vaccine immunization in India: utility of the MSD platform

For the efficacy of COVID-19 vaccines, emergence of variants accumulating immune-escape mutations remains a major concern. We analyzed the anti-variant (n = 10) neutralization activity of sera from COVID-19 patients infected with Wuhan (B.1), Kappa, and Delta variants and COVISHIELD vaccine recipien...

Descripción completa

Detalles Bibliográficos
Autores principales: Patil, Rajashree, Palkar, Sonali, Mishra, Akhileshchandra, Patil, Rahul, Arankalle, Vidya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277512/
https://www.ncbi.nlm.nih.gov/pubmed/37342350
http://dx.doi.org/10.3389/fimmu.2023.1181991

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277512/
https://www.ncbi.nlm.nih.gov/pubmed/37342350
http://dx.doi.org/10.3389/fimmu.2023.1181991

Ejemplares similares